4-(6-(4-(4-Methylpiperazin-1-yl)phenyl)thieno[2,3-d]-pyrimidin-4-yl)-N-propylpiperazine-1-carboxamide

ID: ALA4849461

PubChem CID: 164612111

Max Phase: Preclinical

Molecular Formula: C25H33N7OS

Molecular Weight: 479.65

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCNC(=O)N1CCN(c2ncnc3sc(-c4ccc(N5CCN(C)CC5)cc4)cc23)CC1

Standard InChI:  InChI=1S/C25H33N7OS/c1-3-8-26-25(33)32-15-13-31(14-16-32)23-21-17-22(34-24(21)28-18-27-23)19-4-6-20(7-5-19)30-11-9-29(2)10-12-30/h4-7,17-18H,3,8-16H2,1-2H3,(H,26,33)

Standard InChI Key:  WZUNWICXXYDGBK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   14.7031  -13.2191    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9924  -13.6348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9924  -14.4620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7069  -14.8736    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4214  -14.4620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4214  -13.6348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7069  -15.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9878  -16.1109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9878  -16.9374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7050  -17.3539    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4211  -16.9316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4211  -16.1087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2022  -15.8502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6881  -16.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2116  -17.1791    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.5123  -16.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9325  -17.2247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7590  -17.2247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1662  -16.4987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7451  -15.7824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9201  -15.7824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9893  -16.4903    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.4022  -17.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2217  -17.1923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6298  -16.4771    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.2123  -15.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3866  -15.7714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4529  -16.4719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7013  -12.3961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4132  -11.9829    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9876  -11.9861    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1269  -12.3928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8388  -11.9798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5594  -12.3936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 12 11  2  0
 12  7  1  0
 13 12  1  0
 14 13  2  0
 15 14  1  0
 11 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
  1 29  1  0
 29 30  1  0
 29 31  2  0
 30 32  1  0
 32 33  1  0
 33 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4849461

    ---

Associated Targets(Human)

FLT4 Tclin Vascular endothelial growth factor receptor 3 (3216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-436 (532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 479.65Molecular Weight (Monoisotopic): 479.2467AlogP: 3.35#Rotatable Bonds: 5
Polar Surface Area: 67.84Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.84CX LogP: 3.44CX LogD: 2.86
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.61Np Likeness Score: -1.96

References

1. Li Y, Yang G, Zhang J, Tang P, Yang C, Wang G, Chen J, Liu J, Zhang L, Ouyang L..  (2021)  Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer.,  64  (16.0): [PMID:34351741] [10.1021/acs.jmedchem.1c00678]

Source